Prolonged Neurological and Musculoskeletal Symptoms Following Shingrix Vaccination
<b>Background and Clinical Significance</b>: The recombinant zoster vaccine (Shingrix) helps prevent shingles and its complications in adults 50 and older. While minor side effects are common, severe adverse reactions are thought to be rare, and long-term side effects are not well docume...
Saved in:
| Main Authors: | Sabrina Hollar, Amna Khalid, Benjamin D. Brooks, Michael Wons |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Series: | Reports |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2571-841X/7/4/83 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bibliometric analysis and visualization mapping of herpes zoster vaccine publications from 1999 to 2024
by: Wenli Gao, et al.
Published: (2025-07-01) -
Post-marketing safety surveillance for the recombinant zoster vaccine (Shingrix), vaccine adverse event reporting system, United States, October 2017–April 2024
by: Yamin Shu, et al.
Published: (2025-02-01) -
The safety of co-administration of recombinant zoster vaccine (Shingrix) and influenza vaccines in the elderly in VAERS during 2018–2024
by: Yihao Li, et al.
Published: (2025-12-01) -
Preventing the risk of iatrogenic harm when assessing and diagnosing functional neurological disorders and other functional somatic symptoms
by: Giovanni Stanghellini, et al.
Published: (2024-01-01) -
A case of aortic dissection presenting primarily with fever and bilateral lower limb neurological symptoms
by: Chenqi Liu, et al.
Published: (2025-08-01)